Thierry Pagé holds a chemical engineering degree from Polytechnique Montréal (Canada) and pursued graduate studies in applied sciences at Université de Louvain (Belgium) and in Management at MIT Sloan, Cambridge (USA). Thierry is a seasoned executive with a successful track record in entrepreneurial management, technology development, commercialization and intellectual property protection, in high-tech and health technologies. Before joining Starpax Biopharma, he held a number of senior positions, including founding CEO at Odotech Inc. and Senior Director, Sciences & Engineering at Univalor (the Technology Transfer Office for University of Montréal, its six affiliated research hospitals and Polytechnique Montréal).
Thierry Pagé
